Rosacea: from multifactorial pathogenesis to modern treatment methods

Rosacea is a chronic inflammatory disease of the facial skin characterized by high prevalence among people of active age. Its development is a multifactorial process caused by complex interactions of genetic predisposition, immune mechanisms, vascular hyperreactivity and numerous lifestyle and environmental factors. In rosacea pathogenesis, a special role is given to the activation of mechanisms of immune inflammation, which is carried out with the involvement of toll-like receptors 2 (TLR2) and cathelicidin LL-37, promoting the production of active forms of oxygen and increase of the expression of anti-inflammatory cytokines and matrix metalloproteinases. Disruption of the epidermal barrier function, formed by transepidermal water loss, increased skin pH and exposure to ultraviolet radiation, is an important component of the pathological process in rosacea. Published data show the association of rosacea development with vascular homeostasis abnormality and vasodilation, mediated by the action of transient receptor potential channels, as well as the density of skin colonization by Demodex mites, promoting the activation of TLR2 and production of inflammation mediators. Currently, topical and systemic drugs are the basis of rosacea therapy. Agents that provide antiparasitic (ivermectin) and antimicrobial (metronidazole, benzoyl peroxide) action, KLK5 inhibitors (azelaic acid) and α2-adrenergic receptor agonists (brimonidine, oxymetazoline) are used for topical therapy. Rosacea systemic therapy regimens may include antibacterial drugs (doxycycline, minocycline, azithromycin), retinoids (isotretinoin) as well as β-adrenergic receptor agonists (propranolol, carvedilol). In resistant and severe forms of pathological process, it is advisable to prescribe combination therapy schemes including topical agents, systemic drugs and (or) methods based on the use of preformed physical factors. It is becoming increasingly important to search for new treatment methods focused on the various components of disease pathogenesis.

Authors

Institutions

Publication Details

Journal
Russian Journal of Clinical Dermatology and Venereology
Published
2026-03-16
DOI
https://doi.org/10.17116/klinderma20262501123
Primary Topic
Acne and Rosacea Treatments and Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rosacea: from multifactorial pathogenesis to modern treatment methods

I.V. Seraya, T.A. Volodkina, L.M. Suleyman, S.V. Murakov
Russian Journal of Clinical Dermatology and Venereology
Acne and Rosacea Treatments and Effects
article

Rosacea: from multifactorial pathogenesis to modern treatment methods

I.V. Seraya, T.A. Volodkina, L.M. Suleyman, S.V. Murakov
article en

Abstract

Rosacea is a chronic inflammatory disease of the facial skin characterized by high prevalence among people of active age. Its development is a multifactorial process caused by complex interactions of genetic predisposition, immune mechanisms, vascular hyperreactivity and numerous lifestyle and environmental factors. In rosacea pathogenesis, a special role is given to the activation of mechanisms of immune inflammation, which is carried out with the involvement of toll-like receptors 2 (TLR2) and cathelicidin LL-37, promoting the production of active forms of oxygen and increase of the expression of anti-inflammatory cytokines and matrix metalloproteinases. Disruption of the epidermal barrier function, formed by transepidermal water loss, increased skin pH and exposure to ultraviolet radiation, is an important component of the pathological process in rosacea. Published data show the association of rosacea development with vascular homeostasis abnormality and vasodilation, mediated by the action of transient receptor potential channels, as well as the density of skin colonization by Demodex mites, promoting the activation of TLR2 and production of inflammation mediators. Currently, topical and systemic drugs are the basis of rosacea therapy. Agents that provide antiparasitic (ivermectin) and antimicrobial (metronidazole, benzoyl peroxide) action, KLK5 inhibitors (azelaic acid) and α2-adrenergic receptor agonists (brimonidine, oxymetazoline) are used for topical therapy. Rosacea systemic therapy regimens may include antibacterial drugs (doxycycline, minocycline, azithromycin), retinoids (isotretinoin) as well as β-adrenergic receptor agonists (propranolol, carvedilol). In resistant and severe forms of pathological process, it is advisable to prescribe combination therapy schemes including topical agents, systemic drugs and (or) methods based on the use of preformed physical factors. It is becoming increasingly important to search for new treatment methods focused on the various components of disease pathogenesis.

Russian Journal of Clinical Dermatology and VenereologyVol. 25(1)
DeKalb Medical Center (US), Federal Medical-Biological Agency (RU)
Openalex Percentile: Top 19%
Acne and Rosacea Treatments and Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.